• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨性别者健康与衰老和绝经的影响。

Transgender health and the impact of aging and menopause.

机构信息

Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Melbourne, Australia.

Department of Endocrinology, Austin Health, Heidelberg, Australia.

出版信息

Climacteric. 2023 Jun;26(3):256-262. doi: 10.1080/13697137.2023.2176217. Epub 2023 Apr 3.

DOI:10.1080/13697137.2023.2176217
PMID:37011669
Abstract

Gender affirming hormone therapy (GAHT) is used by many transgender people to reduce gender incongruence and improve psychological functioning. As GAHT shares many similarities with menopausal hormone therapy, clinicians supporting people through menopause are ideally placed to manage GAHT. This narrative review provides an overview of transgender health and discusses long-term effects of GAHT to consider when managing transgender individuals across the lifespan. Menopause is less relevant for transgender individuals who take GAHT (often given lifelong) to achieve sex steroid concentrations generally in the range of the affirmed gender. For people using feminizing hormone therapy, there is an elevated risk of venous thromboembolism, myocardial infarction, stroke and osteoporosis relative to cisgender individuals. For trans people using masculinizing hormone therapy, there is an increased risk of polycythemia, probable higher risk of myocardial infarction and pelvic pain which is poorly understood. Proactive mitigation of cardiovascular risk factors is important for all transgender people and optimization of bone health is important for those using feminizing hormones. With a lack of research to guide GAHT in older age, a shared decision-making approach is recommended for the provision of GAHT to achieve individual goals whilst minimizing potential adverse effects.

摘要

性别肯定激素治疗(GAHT)被许多跨性别者用于减少性别不一致和改善心理功能。由于 GAHT 与更年期激素治疗有许多相似之处,因此支持处于更年期的人的临床医生最适合管理 GAHT。本叙述性综述概述了跨性别者的健康状况,并讨论了 GAHT 的长期影响,以便在跨性别者的整个生命周期中进行管理。对于接受 GAHT(通常终生服用)以达到与所认同性别范围内的性激素浓度相似的跨性别者,更年期的相关性较低。对于使用女性化激素治疗的人,与顺性别者相比,静脉血栓栓塞、心肌梗死、中风和骨质疏松症的风险升高。对于使用男性化激素治疗的跨性别者,存在红细胞增多症的风险增加,可能存在更高的心肌梗死风险和骨盆疼痛,这一点尚未得到充分理解。积极缓解心血管危险因素对所有跨性别者都很重要,优化骨骼健康对使用女性化激素的人也很重要。由于缺乏研究来指导老年时期的 GAHT,建议采用共同决策方法来提供 GAHT,以实现个人目标,同时最大限度地减少潜在的不良影响。

相似文献

1
Transgender health and the impact of aging and menopause.跨性别者健康与衰老和绝经的影响。
Climacteric. 2023 Jun;26(3):256-262. doi: 10.1080/13697137.2023.2176217. Epub 2023 Apr 3.
2
Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.澳大利亚跨性别和性别多样化成年人的性别肯定激素治疗。
Intern Med J. 2024 Sep;54(9):1450-1457. doi: 10.1111/imj.16413. Epub 2024 Jul 26.
3
Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.退伍军人健康管理局的临床医生根据临床指南建议启动性别肯定激素治疗。
Front Endocrinol (Lausanne). 2024 May 10;15:1086158. doi: 10.3389/fendo.2024.1086158. eCollection 2024.
4
Changes in affect variability after starting gender-affirming hormone therapy.开始性别确认激素治疗后情感变异性的变化。
Psychoneuroendocrinology. 2025 May;175:107408. doi: 10.1016/j.psyneuen.2025.107408. Epub 2025 Feb 21.
5
Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.跨性别和性别多样化人群的性别肯定激素治疗:治疗方式、监测和风险概述。
Neurourol Urodyn. 2023 Jun;42(5):903-920. doi: 10.1002/nau.25097. Epub 2022 Nov 20.
6
Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.自我开具性别确认激素疗法的跨性别女性体内激素浓度:一项回顾性研究。
J Sex Med. 2022 May;19(5):864-871. doi: 10.1016/j.jsxm.2022.02.023. Epub 2022 Apr 1.
7
Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review.评估和应对跨性别肯定护理谱中的静脉血栓栓塞风险:综述。
Endocr Pract. 2023 Apr;29(4):272-278. doi: 10.1016/j.eprac.2022.12.008. Epub 2022 Dec 17.
8
Transgender patients and gender-affirming hormone therapy through the mid-life.中年跨性别患者与性别确认激素疗法
Maturitas. 2024 Nov;189:108093. doi: 10.1016/j.maturitas.2024.108093. Epub 2024 Aug 20.
9
Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.跨性别者接受性别肯定激素治疗后肝酶水平的纵向变化。
J Sex Med. 2021 Sep;18(9):1662-1675. doi: 10.1016/j.jsxm.2021.06.011. Epub 2021 Aug 5.
10
Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.跨性别退伍军人的性别肯定激素治疗与代谢综合征。
JAMA Netw Open. 2024 Jul 1;7(7):e2419696. doi: 10.1001/jamanetworkopen.2024.19696.

引用本文的文献

1
Injectable Aesthetic Treatments for Improving Facial Skin Quality in Transgender Patients With or Without Gender-Affirming Hormone Therapy.用于改善接受或未接受性别确认激素治疗的跨性别患者面部皮肤质量的注射美容治疗
J Cosmet Dermatol. 2025 Sep;24 Suppl 4(Suppl 4):e70318. doi: 10.1111/jocd.70318.
2
Protocol for a global menopause priority setting partnership.全球更年期优先事项设定伙伴关系协议。
BMJ Open. 2025 Jun 4;15(6):e096401. doi: 10.1136/bmjopen-2024-096401.
3
Where Are the Knowledge Gaps in Menopause Across a Population? A National Cross-Sectional Survey in Wales.
整个人口中更年期的知识空白在哪里?威尔士的一项全国性横断面调查。
Int J Environ Res Public Health. 2025 Feb 14;22(2):287. doi: 10.3390/ijerph22020287.
4
Exploring the role of sex hormones and gender diversity in multiple sclerosis.探索性激素和性别多样性在多发性硬化症中的作用。
Nat Rev Neurol. 2025 Jan;21(1):48-62. doi: 10.1038/s41582-024-01042-x. Epub 2024 Dec 11.
5
Brazilian Guideline on Menopausal Cardiovascular Health - 2024.《巴西更年期心血管健康指南 - 2024》
Rev Bras Ginecol Obstet. 2024 Oct 15;46. doi: 10.61622/rbgo/2024rbgo100. eCollection 2024.
6
Gender Reassignment and the Role of the Laboratory in Monitoring Gender-Affirming Hormone Therapy.性别重置与实验室在监测性别确认激素治疗中的作用。
J Clin Med. 2024 Aug 29;13(17):5134. doi: 10.3390/jcm13175134.
7
Brazilian Guideline on Menopausal Cardiovascular Health - 2024.《巴西更年期心血管健康指南 - 2024》
Arq Bras Cardiol. 2024 Aug 16;121(7):e20240478. doi: 10.36660/abc.20240478.
8
Lesbian, gay, bisexual, transgender and queer (LGBTQ+) menopause: Literature review, knowledge gaps and research agenda.女同性恋、男同性恋、双性恋、跨性别者及酷儿群体(LGBTQ+)的更年期:文献综述、知识空白与研究议程
Health (London). 2024 Aug 8:13634593241270923. doi: 10.1177/13634593241270923.
9
Getting old in the desired gender: a systematic review on aging diseases in transgender people.按期望性别变老:跨性别者衰老疾病的系统综述。
J Endocrinol Invest. 2024 Aug;47(8):1851-1862. doi: 10.1007/s40618-024-02353-y. Epub 2024 Jun 21.
10
Impact of Distinct Antiandrogen Exposures on the Plasma Metabolome in Feminizing Gender-affirming Hormone Therapy.不同雄激素拮抗剂暴露对女性性别肯定激素治疗中血浆代谢组的影响。
J Clin Endocrinol Metab. 2024 Oct 15;109(11):2857-2871. doi: 10.1210/clinem/dgae226.